Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

NCT00348400 Phase 4 COMPLETED

Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy

Details

Lead sponsor	Innovative Medical
Phase	Phase 4
Status	COMPLETED

Conditions

• Glaucoma

Interventions

• Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost

Countries

United States